Sorrento closes $150M private placements

Oncology company Sorrento Therapeutics Inc. (NASDAQ:SRNE) closed a set of private placements in which it

Read the full 151 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE